The Wall Street Journal now offers an Avian flu news tracker.
In it is a story wherein a Roche pharmaceutical exec cautions that governments need to do much more than stock up on the antiviral drug Tamiflu to fight any bird-flu pandemic, and says "mad" consumer purchases of the drug to ward off possible bird flu were making it difficult to supply patients for the normal flu season.
To that I would add some words of caution: there is not overwhelming evidence of how Tamiflu would even work against the Avian flu. And there is already at least one case reported of resistance to the drug.
Leave a comment
My policy on commentsI'm adopting the policy of a blog I admire: “Comments are great; obnoxious comments get deleted. Deal." I also won’t post profanity, product pitches, or anything from anyone who doesn’t list what appears to be an actual e-mail address.